{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:35:04Z","timestamp":1790130904638,"version":"4.0.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82404556"],"award-info":[{"award-number":["82404556"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32471525"],"award-info":[{"award-number":["32471525"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jconrel.2024.12.009","type":"journal-article","created":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T09:30:36Z","timestamp":1733823036000},"page":"38-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Construction of novel magnetic systems for cancer immunotherapy via cancer-immunity cycle circuits"],"prefix":"10.1016","volume":"378","author":[{"given":"Linghong","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zonghua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jconrel.2024.12.009_bb0005","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.apsb.2021.08.020","article-title":"Emerging role of natural products in cancer immunotherapy","volume":"12","author":"Dong","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.jconrel.2024.12.009_bb0010","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41577-019-0218-4","article-title":"Tumour-intrinsic resistance to immune checkpoint blockade","volume":"20","author":"Kalbasi","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.jconrel.2024.12.009_bb0015","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41571-019-0218-0","article-title":"Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance","volume":"16","author":"Martins","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.jconrel.2024.12.009_bb0020","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.apsb.2018.03.001","article-title":"The application of CAR-T cell therapy in hematological malignancies: advantages and challenges","volume":"8","author":"Zhao","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"issue":"8","key":"10.1016\/j.jconrel.2024.12.009_bb0025","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.ymthe.2017.06.012","article-title":"Engineering natural killer cells for cancer immunotherapy","volume":"25","author":"Rezvani","year":"2017","journal-title":"Mol. Ther."},{"issue":"31","key":"10.1016\/j.jconrel.2024.12.009_bb0030","article-title":"In situ cocktail nanovaccine for cancer immunotherapy","volume":"10","author":"Liu","year":"2023","journal-title":"Adv. Sci. (Weinheim, Baden-Wurttemberg, Germany)"},{"issue":"1","key":"10.1016\/j.jconrel.2024.12.009_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","article-title":"Oncology meets immunology: the cancer-immunity cycle","volume":"39","author":"Chen","year":"2013","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.jconrel.2024.12.009_bb0040","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.trecan.2017.12.007","article-title":"Re-emergence of dendritic cell vaccines for cancer treatment","volume":"4","author":"Saxena","year":"2018","journal-title":"Trends Cancer"},{"issue":"6","key":"10.1016\/j.jconrel.2024.12.009_bb0045","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41568-021-00346-0","article-title":"Therapeutic cancer vaccines","volume":"21","author":"Saxena","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"11","key":"10.1016\/j.jconrel.2024.12.009_bb0050","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/s41565-023-01453-9","article-title":"Close the cancer-immunity cycle by integrating lipid nanoparticle-mRNA formulations and dendritic cell therapy","volume":"18","author":"Zhang","year":"2023","journal-title":"Nat. Nanotechnol."},{"issue":"1","key":"10.1016\/j.jconrel.2024.12.009_bb0055","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/cr.2016.151","article-title":"Regulatory T cells in cancer immunotherapy","volume":"27","author":"Tanaka","year":"2017","journal-title":"Cell Res."},{"issue":"7","key":"10.1016\/j.jconrel.2024.12.009_bb0060","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1016\/S1470-2045(13)70585-0","article-title":"Clinical use of dendritic cells for cancer therapy","volume":"15","author":"Anguille","year":"2014","journal-title":"Lancet Oncol."},{"issue":"9","key":"10.1016\/j.jconrel.2024.12.009_bb0065","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41573-020-0074-8","article-title":"Antitumour dendritic cell vaccination in a priming and boosting approach","volume":"19","author":"Harari","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"issue":"20","key":"10.1016\/j.jconrel.2024.12.009_bb0070","doi-asserted-by":"crossref","first-page":"18192","DOI":"10.18632\/oncotarget.4145","article-title":"Phase I\/II clinical trial of dendritic-cell based immunotherapy (DCVAC\/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer","volume":"6","author":"Podrazil","year":"2015","journal-title":"Oncotarget"},{"issue":"436","key":"10.1016\/j.jconrel.2024.12.009_bb0075","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aao5931","article-title":"Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer","volume":"10","author":"Tanyi","year":"2018","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2024.12.009_bb0080","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13045-020-00885-3","article-title":"Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy","volume":"13","author":"Li","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"19","key":"10.1016\/j.jconrel.2024.12.009_bb0085","doi-asserted-by":"crossref","first-page":"8216","DOI":"10.1039\/D2CS00387B","article-title":"Discovery of small molecule ligands for the von Hippel-Lindau (VHL) E3 ligase and their use as inhibitors and PROTAC degraders","volume":"51","author":"Diehl","year":"2022","journal-title":"Chem. Soc. Rev."},{"issue":"11","key":"10.1016\/j.jconrel.2024.12.009_bb0090","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.tips.2023.05.008","article-title":"Leveraging aptamers for targeted protein degradation","volume":"44","author":"Yang","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2024.12.009_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e08702","article-title":"Galactose-decorated liver tumor-specific nanoliposomes incorporating selective BRD4-targeted PROTAC for hepatocellular carcinoma therapy","volume":"8","author":"Saraswat","year":"2022","journal-title":"Heliyon"},{"issue":"14","key":"10.1016\/j.jconrel.2024.12.009_bb0100","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202107461","article-title":"Antigen capture and immune modulation by bacterial outer membrane vesicles as in situ vaccine for cancer immunotherapy post-photothermal therapy","volume":"18","author":"Li","year":"2022","journal-title":"Small (Weinheim an der Bergstrasse, Germany)"},{"issue":"7","key":"10.1016\/j.jconrel.2024.12.009_bb0105","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202007293","article-title":"Supramolecular assembled programmable nanomedicine as in situ cancer vaccine for cancer immunotherapy","volume":"33","author":"Zhang","year":"2021","journal-title":"Adv. Mater."},{"issue":"41","key":"10.1016\/j.jconrel.2024.12.009_bb0110","doi-asserted-by":"crossref","first-page":"23002","DOI":"10.1016\/j.ijhydene.2019.07.025","article-title":"Au nanoparticles decorated on magnetic nanocomposite (GO-Fe3O4\/Dop\/Au) as a recoverable catalyst for degradation of methylene blue and methyl orange in water","volume":"44","author":"Esmaeili","year":"2019","journal-title":"Int. J. Hydrog. Energy"},{"issue":"22","key":"10.1016\/j.jconrel.2024.12.009_bb0115","doi-asserted-by":"crossref","first-page":"10146","DOI":"10.1039\/C5NR01843A","article-title":"Nanostructured porous manganese carbonate spheres with capacitive effects on the high lithium storage capability","volume":"7","author":"Kang","year":"2015","journal-title":"Nanoscale"},{"issue":"11","key":"10.1016\/j.jconrel.2024.12.009_bb0120","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/s41422-020-00395-4","article-title":"Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy","volume":"30","author":"Lv","year":"2020","journal-title":"Cell Res."},{"issue":"4","key":"10.1016\/j.jconrel.2024.12.009_bb0125","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.immuni.2018.03.017","article-title":"Manganese increases the sensitivity of the cGAS-STING pathway for double-stranded DNA and is required for the host defense against DNA viruses","volume":"48","author":"Wang","year":"2018","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.jconrel.2024.12.009_bb0130","doi-asserted-by":"crossref","first-page":"627","DOI":"10.17344\/acsi.2016.2386","article-title":"Fe3O4@ SiO2-NH2 nanocomposite as a robust and effective catalyst for the one-pot synthesis of polysubstituted dihydropyridines","volume":"63","author":"Ghasemzadeh","year":"2016","journal-title":"Acta Chim. Slov."},{"key":"10.1016\/j.jconrel.2024.12.009_bb0135","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.indcrop.2013.07.063","article-title":"Microwave assisted synthesis of bacterial cellulose-calcium carbonate composites","volume":"50","author":"Stoica-Guzun","year":"2013","journal-title":"Ind. Crop. Prod."},{"issue":"20","key":"10.1016\/j.jconrel.2024.12.009_bb0140","doi-asserted-by":"crossref","first-page":"6264","DOI":"10.1158\/0008-5472.CAN-13-0122-T","article-title":"BRD4 sustains melanoma proliferation and represents a new target for epigenetic therapy","volume":"73","author":"Segura","year":"2013","journal-title":"Cancer Res."},{"issue":"Pt 3","key":"10.1016\/j.jconrel.2024.12.009_bb0145","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.semcancer.2022.03.009","article-title":"Ferroptosis, necroptosis, and pyroptosis in the tumor microenvironment: perspectives for immunotherapy of SCLC","volume":"86","author":"Niu","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.jconrel.2024.12.009_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.705361","article-title":"Immunogenic cell death induction by ionizing radiation","volume":"12","author":"Zhu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2024.12.009_bb0155","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1016\/j.ijbiomac.2020.07.299","article-title":"Quantitative approach to study secondary structure of proteins by FT-IR spectroscopy, using a model wheat gluten system","volume":"164","author":"Fevzioglu","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2024.12.009_bb0160","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.ijbiomac.2020.06.171","article-title":"Polymerization degree of chitosan affects structural and compositional changes in the cell walls, membrane lipids, and proteins in the leaves of Ipomoea purpurea: an FT-IR spectroscopy study","volume":"162","author":"Acemi","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"issue":"2","key":"10.1016\/j.jconrel.2024.12.009_bb0165","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10400","article-title":"Magnetic nanoparticles enhance the cellular immune response of dendritic cell tumor vaccines by realizing the cytoplasmic delivery of tumor antigens","volume":"8","author":"Huang","year":"2023","journal-title":"Bioeng. Transl. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2024.12.009_bb0170","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/cr.2016.157","article-title":"Dendritic cell-based immunotherapy","volume":"27","author":"Sabado","year":"2017","journal-title":"Cell Res."},{"issue":"1","key":"10.1016\/j.jconrel.2024.12.009_bb0175","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1038\/s41467-021-24331-1","article-title":"Microbial short-chain fatty acids modulate CD8(+) T cell responses and improve adoptive immunotherapy for cancer","volume":"12","author":"Luu","year":"2021","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.jconrel.2024.12.009_bb0180","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ccell.2022.02.003","article-title":"CD8(+) T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4","volume":"40","author":"Liao","year":"2022","journal-title":"Cancer Cell"},{"issue":"12","key":"10.1016\/j.jconrel.2024.12.009_bb0185","first-page":"3833","article-title":"TNF-?? Is critical for antitumor but not antiviral T cell immunity in mice","volume":"117","author":"Calzascia","year":"2008","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.jconrel.2024.12.009_bb0190","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1073\/pnas.72.9.3666","article-title":"An endotoxin-induced serum factor that causes necrosis of tumors","volume":"72","author":"Carswell","year":"1975","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2024.12.009_bb0195","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cytogfr.2018.01.002","article-title":"Interleukin-6: a promising cytokine to support liver regeneration and adaptive immunity in liver pathologies","volume":"39","author":"Naseem","year":"2018","journal-title":"Cytokine Growth Factor Rev."},{"issue":"8","key":"10.1016\/j.jconrel.2024.12.009_bb0200","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202106654","article-title":"Tumor-microenvironment-activatable polymer nano-immunomodulator for precision cancer photoimmunotherapy","volume":"34","author":"Liu","year":"2022","journal-title":"Adv. Mater."},{"issue":"5","key":"10.1016\/j.jconrel.2024.12.009_bb0205","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41423-023-00990-6","article-title":"Dendritic cell subsets in cancer immunity and tumor antigen sensing","volume":"20","author":"Del Prete","year":"2023","journal-title":"Cell. Mol. Immunol."},{"issue":"22","key":"10.1016\/j.jconrel.2024.12.009_bb0210","article-title":"Immunogenic cell death activates the tumor immune microenvironment to boost the immunotherapy efficiency","volume":"9","author":"Li","year":"2022","journal-title":"Adv. Sci. (Weinheim, Baden-Wurttemberg, Germany)"},{"issue":"4","key":"10.1016\/j.jconrel.2024.12.009_bb0215","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ccell.2020.12.023","article-title":"Stanniocalcin 1 is a phagocytosis checkpoint driving tumor immune resistance","volume":"39","author":"Lin","year":"2021","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.jconrel.2024.12.009_bb0220","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41416-018-0167-x","article-title":"S100B and LDH as early prognostic markers for response and overall survival in melanoma patients treated with anti-PD-1 or combined anti-PD-1 plus anti-CTLA-4 antibodies","volume":"119","author":"Wagner","year":"2018","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.jconrel.2024.12.009_bb0225","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20180005","article-title":"Carnosic acid impedes cell growth and enhances anticancer effects of carmustine and lomustine in melanoma","volume":"38","author":"Lin","year":"2018","journal-title":"Biosci. Rep."},{"issue":"5386","key":"10.1016\/j.jconrel.2024.12.009_bb0230","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1126\/science.282.5386.121","article-title":"An antimicrobial activity of cytolytic T cells mediated by granulysin","volume":"282","author":"Stenger","year":"1998","journal-title":"Science"},{"issue":"23","key":"10.1016\/j.jconrel.2024.12.009_bb0235","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232315377","article-title":"Artemisia gmelinii extract alleviates allergic airway inflammation via balancing TH1\/TH2 homeostasis and inhibiting mast cell degranulation","volume":"23","author":"Nguyen","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.jconrel.2024.12.009_bb0240","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","article-title":"Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion","volume":"21","author":"Jhunjhunwala","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.jconrel.2024.12.009_bb0245","first-page":"882","article-title":"Multifunctional oncolytic nanoparticles deliver self-replicating IL-12 RNA to eliminate established tumors and prime systemic immunity","volume":"1","author":"Li","year":"2020","journal-title":"Nat. Can."},{"key":"10.1016\/j.jconrel.2024.12.009_bb0250","doi-asserted-by":"crossref","first-page":"6301","DOI":"10.1038\/ncomms7301","article-title":"Real-time tracking of cell cycle progression during CD8+ effector and memory T-cell differentiation","volume":"6","author":"Kinjyo","year":"2015","journal-title":"Nat. Commun."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924008514?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924008514?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T12:46:47Z","timestamp":1778244407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365924008514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":50,"alternative-id":["S0168365924008514"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.12.009","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Construction of novel magnetic systems for cancer immunotherapy via cancer-immunity cycle circuits","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}